Early Administration of Low-Dose Aspirin for the Prevention of Preterm and Term Preeclampsia: A Systematic Review and Meta-Analysis - Wikidata - awgldk - TriplyDB

Early Administration of Low-Dose Aspirin for the Prevention of Preterm and Term Preeclampsia: A Systematic Review and Meta-Analysis

Early Administration of Low-Dose Aspirin for the Prevention of Preterm and Term Preeclampsia: A Systematic Review and Meta-Analysis

http://www.wikidata.org/entity/Q22306400

about

Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis Combined Screening for Early Detection of Pre-Eclampsia Recent advances in the diagnosis and management of pre-eclampsia Is oocyte donation a risk factor for preeclampsia? A systematic review and meta-analysis Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).Usefulness of circulating microRNAs for the prediction of early preeclampsia at first-trimester of pregnancy EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy.Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.Estimated reductions in provider-initiated preterm births and hospital length of stay under a universal acetylsalicylic acid prophylaxis strategy: a retrospective cohort study.Early prediction of preeclampsia Preeclampsia from a renal point of view: Insides into disease models, biomarkers and therapy.Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort.First-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55,974 women.Risk threshold for starting low dose aspirin in pregnancy to prevent preeclampsia: an opportunity at a low cost.Prediction and prevention of early-onset pre-eclampsia: impact of aspirin after first-trimester screening.Maternal Serum Screening Markers and Adverse Outcome: A New Perspective Why non-invasive maternal hemodynamics assessment is clinically relevant in early pregnancy: a literature review First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening Study First trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with pre-eclampsia: a case control study.Remodeling of the gut microbiota and structural shifts in Preeclampsia patients in South China.Cluster analysis to estimate the risk of preeclampsia in the high-risk Prediction and Prevention of Preeclampsia and Intrauterine Growth Restriction (PREDO) study.Biological rhythms and preeclampsia.Preeclampsia in high risk women is characterized by risk group-specific abnormalities in serum biomarkers.Early initiation of low-dose aspirin for reduction in preeclampsia risk in high-risk women: a secondary analysis of the MFMU High-Risk Aspirin Study.Individual risk assessment of adverse pregnancy outcome by multivariate regression analysis may serve as basis for drug intervention studies: retrospective analysis of 426 high-risk patients including ethical aspects Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE).Preterm preeclampsia in relation to country of birth.Aspirin for prevention of preeclampsia in lupus pregnancy.Antithrombotic treatment for pregnancy complications: which path for the journey to precision medicine?First-trimester maternal factors and biomarker screening for preeclampsia.Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation.First trimester screening can predict adverse pregnancy outcomes.Screening for Down syndrome.Effect of aspirin in prevention of adverse pregnancy outcome in women with elevated alpha-fetoprotein.Ischemic placental syndrome--prediction and new disease monitoring.Subsequent pregnancy outcome after mid-trimester termination of pregnancy for preeclampsia.Effects of context-aware patient guidance on blood pressure self-measurement adherence levels.The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review.

P2860

Q26752308-7FEDDC0E-A91D-4806-A514-809823BDC3E0 Q26781800-2138FD77-B022-493D-90E4-DBA995DEC473 Q26801503-2A543BF9-5FF1-4205-A1A4-204A29F46067 Q26996839-36DBFC58-403E-485D-88C0-E022C87574F6 Q30251726-DC87B464-B610-42EC-85DD-2DB144AEAE45 Q33579089-2C49EEBF-CC75-46C1-B90B-7CB44D11628C Q33581738-865A603C-ECEA-446D-B4D5-E05E53978C51 Q33731711-38070751-54F7-4AF1-9AB2-3C2C402351A5 Q33844319-FB6E252D-859D-4756-A948-E98D020B71B7 Q33863973-D35552DE-40EA-4A3D-BA35-15261CF4A916 Q33874882-AE95B3E2-5EA6-4D4E-886D-8531CB7A98F2 Q34022344-D21572E3-4804-4516-8641-BE9579A0686E Q34453242-FA34096D-C01B-44B9-AA38-3E69B46D4B80 Q34714619-C7A279FD-90E6-460F-8FB5-6973E01C0991 Q35067015-FE917068-B331-46EC-9BFA-9056FCF3B70A Q35196095-B48FFDE4-7ADD-46D7-B1E7-0E57BD780B99 Q35560414-A8C02931-DC9A-4EBF-BA98-9192529C9B85 Q35667145-EC563FCB-3550-4008-B167-8F4EF8937EC6 Q36160792-CD9DD43E-2B60-4218-8799-0FE3D826141F Q36184116-6CED43B0-72E0-4DCD-8367-B22E580F4D02 Q36204185-9CF4958C-6C04-4FF4-90A7-25575D16E02B Q36227409-9FB39987-A1A4-44E3-8735-859D69BF034C Q36325415-29F98C19-35B5-44EA-8D24-E69E3BFA2CBD Q36746936-39E7ECED-2375-41DB-AD9A-E5F09C8A649A Q36798210-B205E209-E878-483F-A8AD-92B3C033F586 Q36819758-AE1D0493-9A83-43E7-9D7A-19AA69699066 Q36927599-166863C2-DF8E-42E1-85AE-EE010DADA975 Q37063617-221B7BCA-B393-4A5B-BB86-C17EA8A4E184 Q37223647-2247FE68-B746-422E-9FDF-87AE01E1615E Q37687986-54C2D49D-0987-4EC3-8727-D537E006F534 Q38193203-49D300C1-80D7-4991-B03A-B43C5E06ECDD Q38207000-387F2D59-A346-41C9-8E30-9106B423CBD7 Q38209622-09A155EA-38C2-432E-B821-560E5644AAA4 Q38210332-BB89E32A-E603-4945-8647-FC171E1D0EB9 Q38235996-9E708ADD-9703-4C1B-8069-E3923449EA7E Q38313749-66577E9A-B970-4708-B922-4B61B7A8F564 Q38601408-D61C79D7-34BC-40F3-A4F9-A606ED4C51F7 Q38603753-92B7CE9D-A54F-4EAA-B854-1FE40AC9058B Q38658584-F2B0633F-8E31-4273-B663-987EC33BCAAA Q38844344-B306B741-638B-4D4C-BEF8-AD59A865C5A2

P2860

Early Administration of Low-Dose Aspirin for the Prevention of Preterm and Term Preeclampsia: A Systematic Review and Meta-Analysis

http://www.wikidata.org/entity/Q22306400

description

2012 nî lūn-bûn

@nan

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Early Administration of Low-Do ...... matic Review and Meta-Analysis

@ast

Early Administration of Low-Do ...... matic Review and Meta-Analysis

@en

Early Administration of Low-Do ...... matic Review and Meta-Analysis

@en-gb

Early Administration of Low-Do ...... matic Review and Meta-Analysis

@nl

type

label

Early Administration of Low-Do ...... matic Review and Meta-Analysis

@ast

Early Administration of Low-Do ...... matic Review and Meta-Analysis

@en

Early Administration of Low-Do ...... matic Review and Meta-Analysis

@en-gb

Early Administration of Low-Do ...... matic Review and Meta-Analysis

@nl

altLabel

Early administration of low-do ...... matic review and meta-analysis

@en

prefLabel

Early Administration of Low-Do ...... matic Review and Meta-Analysis

@ast

Early Administration of Low-Do ...... matic Review and Meta-Analysis

@en

Early Administration of Low-Do ...... matic Review and Meta-Analysis

@en-gb

Early Administration of Low-Do ...... matic Review and Meta-Analysis

@nl

P1433

Q22306400-FB3641A9-8043-461C-B2B2-E2464E180BBD

P1476

Q22306400-F14640ED-1C87-4810-9B14-BA3C9AA6E161

P2093

Q22306400-17A688B2-2426-4EA8-8A38-2926EFDF9FC7

Q22306400-4FE5F85B-3F2D-4995-8192-241C6966431F

Q22306400-6AE50F7E-5174-4A15-83E6-3697326FB3C4

Q22306400-7EA8C5B9-55D8-46F5-90AB-CBABEED3D68B

Q22306400-9DC1AA27-7ADD-4464-AD77-B28C687F92DC

Q22306400-D1C1ACD3-B49D-4CE1-B6A4-65A6492CCF5F

Q22306400-EDC47BFE-EEDB-4F6D-B473-CB6520579615

Q22306400-FAF1EF6E-8BB2-4CCC-A01F-B7D043833FC8

P304

Q22306400-A926AA4E-BF88-4B54-968B-0B0738446973

P31

Q22306400-3DEC9786-E68E-4665-98E0-06BA2ABB9F8F

Q22306400-B086D2FD-AB52-401D-BE24-7F82B01FEC93

Q22306400-CD055134-BEAF-4B14-90FB-3218119102D4

P3181

Q22306400-1A4A3581-1917-4BDA-B638-F7085D6471EC

P356

Q22306400-CE83A7A7-253B-451B-B540-A427E5CE5D0A

P407

Q22306400-FB71B37B-C56F-439F-B65E-39506C3C6DBB

P433

Q22306400-0FC62800-195A-4481-8292-3907AC71E40F

P478

Q22306400-EB00AC87-167A-491C-BDFF-B8FD203F00EC

P577

Q22306400-D42F283C-EF0A-4D44-8720-27A99D403EA6

P5875

Q22306400-24AB4763-958F-40C6-8C91-5DCC8E7AABC6

P698

Q22306400-D5FC4046-059D-4801-A9F4-FD3451BFFE40

P921

Q22306400-3E706F1C-B83B-44E1-B2F7-435049F71BEB

Q22306400-447674F9-5FAB-4C67-973D-0B6196345C18

Q22306400-668781B3-C60E-4941-B59B-DD9972C2C71B

Q22306400-B4F675E9-24FA-46EE-B42A-B6354A5744DE

Q22306400-DFF26897-B9BA-4C96-B118-812733F9764A

P3181

P356

P1433

Fetal Diagnosis and Therapy

P1476

Early Administration of Low-Do ...... matic Review and Meta-Analysis

@en

P2093

Abdelouahab Bakthi

http://www.w3.org/2001/XMLSchema#string

Alaa Ebrashy

http://www.w3.org/2001/XMLSchema#string

Emmanuel Bujold

http://www.w3.org/2001/XMLSchema#string

Kypros Nicolaides

http://www.w3.org/2001/XMLSchema#string

Merja Vainio

http://www.w3.org/2001/XMLSchema#string

Pia Villa

http://www.w3.org/2001/XMLSchema#string

Stéphanie Roberge

http://www.w3.org/2001/XMLSchema#string

Yves Giguère

http://www.w3.org/2001/XMLSchema#string

P304

141-146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P3181

448738

http://www.w3.org/2001/XMLSchema#string

P356

10.1159/000336662

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221970247

http://www.w3.org/2001/XMLSchema#string

P698

22441437

http://www.w3.org/2001/XMLSchema#string

P921

obstetrics and gynaecology